The influence of quipazine on the turnover rate of serotonin.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007700:Kinetics; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D011804:Quinolines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008238:Lysergic Acid Diethylamide; D010293:Pargyline; D008784:Methysergide